JP2017501236A5 - - Google Patents

Download PDF

Info

Publication number: JP2017501236A5
Authority: JP; Japan
Prior art keywords: substituted; alkyl; cycloalkyl; independently hydrogen; heteroatoms selected
Prior art date: 2015-01-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2016562465A

Other languages

English (en)

Japanese (ja)

Other versions

JP6530764B2 (ja

JP2017501236A (ja

Filing date

2015-01-05

Publication date

2018-02-15

2015-01-05 Application filed filed Critical

2015-01-05 Priority claimed from PCT/US2015/010089 external-priority patent/WO2015103509A1/fr

2017-01-12 Publication of JP2017501236A publication Critical patent/JP2017501236A/ja

2018-02-15 Publication of JP2017501236A5 publication Critical patent/JP2017501236A5/ja

2019-06-12 Application granted granted Critical

2019-06-12 Publication of JP6530764B2 publication Critical patent/JP6530764B2/ja

Status Expired - Fee Related legal-status Critical Current

2035-01-05 Anticipated expiration legal-status Critical

Links

125000000217 alkyl group Chemical group 0.000 claims 64
229910052739 hydrogen Inorganic materials 0.000 claims 43
239000001257 hydrogen Substances 0.000 claims 41
125000005842 heteroatom Chemical group 0.000 claims 32
229910052717 sulfur Inorganic materials 0.000 claims 32
229910052760 oxygen Inorganic materials 0.000 claims 31
125000000623 heterocyclic group Chemical group 0.000 claims 25
150000002431 hydrogen Chemical class 0.000 claims 25
125000004432 carbon atom Chemical group C* 0.000 claims 22
125000005843 halogen group Chemical group 0.000 claims 22
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 14
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 14
125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 12
150000001875 compounds Chemical class 0.000 claims 12
150000003839 salts Chemical class 0.000 claims 12
125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 11
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 7
229910052799 carbon Inorganic materials 0.000 claims 6
125000002837 carbocyclic group Chemical group 0.000 claims 5
125000000753 cycloalkyl group Chemical group 0.000 claims 5
125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 4
208000023275 Autoimmune disease Diseases 0.000 claims 3
125000000304 alkynyl group Chemical group 0.000 claims 3
-1 and N Inorganic materials 0.000 claims 3
125000003118 aryl group Chemical group 0.000 claims 3
150000001721 carbon Chemical group 0.000 claims 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
125000001072 heteroaryl group Chemical group 0.000 claims 3
125000003341 7 membered heterocyclic group Chemical group 0.000 claims 2
239000003795 chemical substances by application Substances 0.000 claims 2
208000035475 disorder Diseases 0.000 claims 2
125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
208000030159 metabolic disease Diseases 0.000 claims 2
229910052757 nitrogen Inorganic materials 0.000 claims 2
125000004433 nitrogen atom Chemical group N* 0.000 claims 2
206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
206010009900 Colitis ulcerative Diseases 0.000 claims 1
208000011231 Crohn disease Diseases 0.000 claims 1
208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
206010028980 Neoplasm Diseases 0.000 claims 1
201000004681 Psoriasis Diseases 0.000 claims 1
201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
201000006704 Ulcerative Colitis Diseases 0.000 claims 1
208000024340 acute graft versus host disease Diseases 0.000 claims 1
208000026935 allergic disease Diseases 0.000 claims 1
208000006673 asthma Diseases 0.000 claims 1
201000011510 cancer Diseases 0.000 claims 1
239000003085 diluting agent Substances 0.000 claims 1
201000010099 disease Diseases 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
229910052736 halogen Inorganic materials 0.000 claims 1
150000002367 halogens Chemical class 0.000 claims 1
201000006417 multiple sclerosis Diseases 0.000 claims 1
239000008194 pharmaceutical composition Substances 0.000 claims 1
206010039073 rheumatoid arthritis Diseases 0.000 claims 1
0 *c1ccc(C(C2)(CN(*)C2=C)S(c2cc(*)c(*)cc2)(=O)=O)cc1 Chemical compound *c1ccc(C(C2)(CN(*)C2=C)S(c2cc(*)c(*)cc2)(=O)=O)cc1 0.000 description 102
FZERHIULMFGESH-UHFFFAOYSA-N CC(Nc1ccccc1)=O Chemical compound CC(Nc1ccccc1)=O FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 2
MSDTVSRCMFGEJK-UHFFFAOYSA-N C/[O]=C(/NC1(CC2)CCN2C=O)\NC1=O Chemical compound C/[O]=C(/NC1(CC2)CCN2C=O)\NC1=O MSDTVSRCMFGEJK-UHFFFAOYSA-N 0.000 description 1
ACFUJGFPYWLGTP-UHFFFAOYSA-N CC(C(C1)CN1S(C)(=O)=O)=O Chemical compound CC(C(C1)CN1S(C)(=O)=O)=O ACFUJGFPYWLGTP-UHFFFAOYSA-N 0.000 description 1
OMNAPXPEWSOPER-UHFFFAOYSA-N CC(C(C=C1)=CNC1=O)=O Chemical compound CC(C(C=C1)=CNC1=O)=O OMNAPXPEWSOPER-UHFFFAOYSA-N 0.000 description 1
QZPDKIWJSGURIC-UHFFFAOYSA-N CC(C(CC1)(CCS1(=O)=[O]C)OC)=O Chemical compound CC(C(CC1)(CCS1(=O)=[O]C)OC)=O QZPDKIWJSGURIC-UHFFFAOYSA-N 0.000 description 1
UAYPHJGKQJKYIQ-UHFFFAOYSA-N CC(C(CC1)CCN1C(C(N)=O)=O)=O Chemical compound CC(C(CC1)CCN1C(C(N)=O)=O)=O UAYPHJGKQJKYIQ-UHFFFAOYSA-N 0.000 description 1
JOVRXTKGKAVPLO-UHFFFAOYSA-N CC(C(CC1)CCN1C(C(O)=O)=O)=O Chemical compound CC(C(CC1)CCN1C(C(O)=O)=O)=O JOVRXTKGKAVPLO-UHFFFAOYSA-N 0.000 description 1
ZHNIXAOGHULOMH-UHFFFAOYSA-N CC(C(CCC1)CC1C(O)=O)=O Chemical compound CC(C(CCC1)CC1C(O)=O)=O ZHNIXAOGHULOMH-UHFFFAOYSA-N 0.000 description 1
KIYCCUMLWOUJFC-UHFFFAOYSA-N CC(C(F)(F)F)(C(F)(F)F)OCC(N)=O Chemical compound CC(C(F)(F)F)(C(F)(F)F)OCC(N)=O KIYCCUMLWOUJFC-UHFFFAOYSA-N 0.000 description 1
OMAMJODLZVESCL-UHFFFAOYSA-N CC(C(F)(F)F)(C(F)(F)F)OCCOC Chemical compound CC(C(F)(F)F)(C(F)(F)F)OCCOC OMAMJODLZVESCL-UHFFFAOYSA-N 0.000 description 1
GZZHNVXPOYJJJC-UHFFFAOYSA-N CC(C(NC)=O)=O Chemical compound CC(C(NC)=O)=O GZZHNVXPOYJJJC-UHFFFAOYSA-N 0.000 description 1
ACYFWRHALJTSCF-UHFFFAOYSA-N CC(C)(C)NC(C)=O Chemical compound CC(C)(C)NC(C)=O ACYFWRHALJTSCF-UHFFFAOYSA-N 0.000 description 1
CYWIVTLXZITRMD-UHFFFAOYSA-N CC(C)(C)OC(NC(C)(CC1)CCN1C(C)=O)=O Chemical compound CC(C)(C)OC(NC(C)(CC1)CCN1C(C)=O)=O CYWIVTLXZITRMD-UHFFFAOYSA-N 0.000 description 1
MPKUPQDAEPKIHZ-UHFFFAOYSA-N CC(CC1)(CCN1C(C)=O)C(O)=O Chemical compound CC(CC1)(CCN1C(C)=O)C(O)=O MPKUPQDAEPKIHZ-UHFFFAOYSA-N 0.000 description 1
KZNFPBDHWFRUQG-UHFFFAOYSA-N CC(CC1)(CCN1C(C)=O)NC(C)=O Chemical compound CC(CC1)(CCN1C(C)=O)NC(C)=O KZNFPBDHWFRUQG-UHFFFAOYSA-N 0.000 description 1
HRBUTHOQYPHRND-UHFFFAOYSA-N CC(CC1)(CCN1C(C)=O)O Chemical compound CC(CC1)(CCN1C(C)=O)O HRBUTHOQYPHRND-UHFFFAOYSA-N 0.000 description 1
QCZFKJXXSAZKFL-UHFFFAOYSA-N CC(CC1)(CCS1(=O)=[O]C)C(C)=O Chemical compound CC(CC1)(CCS1(=O)=[O]C)C(C)=O QCZFKJXXSAZKFL-UHFFFAOYSA-N 0.000 description 1
FLZUYXUBDVKWPO-UHFFFAOYSA-N CC(Cc(cc1)ccc1C(O)=O)=O Chemical compound CC(Cc(cc1)ccc1C(O)=O)=O FLZUYXUBDVKWPO-UHFFFAOYSA-N 0.000 description 1
ILRVKOYYFFNXDB-UHFFFAOYSA-N CC(Cc1ccncc1)=O Chemical compound CC(Cc1ccncc1)=O ILRVKOYYFFNXDB-UHFFFAOYSA-N 0.000 description 1
QAKHRNBJPCBSJB-UHFFFAOYSA-N CC(Cc1ccnnc1)=O Chemical compound CC(Cc1ccnnc1)=O QAKHRNBJPCBSJB-UHFFFAOYSA-N 0.000 description 1
HKVMSCXHSSBGRU-UHFFFAOYSA-N CC(Cc1cnccn1)=O Chemical compound CC(Cc1cnccn1)=O HKVMSCXHSSBGRU-UHFFFAOYSA-N 0.000 description 1
PZVZIRMBIYZYDC-UHFFFAOYSA-N CC(Cc1cncnc1)=O Chemical compound CC(Cc1cncnc1)=O PZVZIRMBIYZYDC-UHFFFAOYSA-N 0.000 description 1
MTNALGFZTROQDI-UHFFFAOYSA-N CC(Cc1n[o]nc1C)=O Chemical compound CC(Cc1n[o]nc1C)=O MTNALGFZTROQDI-UHFFFAOYSA-N 0.000 description 1
DBUVTTNCNPGTOY-UHFFFAOYSA-N CC(Cc1nc(O)nc(O)c1)=O Chemical compound CC(Cc1nc(O)nc(O)c1)=O DBUVTTNCNPGTOY-UHFFFAOYSA-N 0.000 description 1
QLVNKBAUCWREPJ-UHFFFAOYSA-N CC(N(C(CC1)C2)C1CC2C(O)=O)=O Chemical compound CC(N(C(CC1)C2)C1CC2C(O)=O)=O QLVNKBAUCWREPJ-UHFFFAOYSA-N 0.000 description 1
YFWJZEMJJMOQAC-UHFFFAOYSA-N CC(N(C1)CC1C(O)=O)=O Chemical compound CC(N(C1)CC1C(O)=O)=O YFWJZEMJJMOQAC-UHFFFAOYSA-N 0.000 description 1
YMWHITJKWDCWKF-UHFFFAOYSA-N CC(N(CC1)CC1(C(N1)=O)NC1=O)=O Chemical compound CC(N(CC1)CC1(C(N1)=O)NC1=O)=O YMWHITJKWDCWKF-UHFFFAOYSA-N 0.000 description 1
CIXFDRNFHDRTBG-UHFFFAOYSA-N CC(N(CC1)CC1c1cccnc1)=O Chemical compound CC(N(CC1)CC1c1cccnc1)=O CIXFDRNFHDRTBG-UHFFFAOYSA-N 0.000 description 1
IRTLGRCDPMVZOH-UHFFFAOYSA-N CC(N(CC1)CC1c1ccncc1)=O Chemical compound CC(N(CC1)CC1c1ccncc1)=O IRTLGRCDPMVZOH-UHFFFAOYSA-N 0.000 description 1
LBKRZDBKDHNFFG-UHFFFAOYSA-N CC(N(CC1)CCC1(C)NS(C)(=O)=O)O Chemical compound CC(N(CC1)CCC1(C)NS(C)(=O)=O)O LBKRZDBKDHNFFG-UHFFFAOYSA-N 0.000 description 1
GNOSSWGJSXNRJG-UHFFFAOYSA-N CC(N(CC1)CCC1C(N(C)C)=O)=O Chemical compound CC(N(CC1)CCC1C(N(C)C)=O)=O GNOSSWGJSXNRJG-UHFFFAOYSA-N 0.000 description 1
DFZQNOGIAYRJHX-UHFFFAOYSA-N CC(N(CC1)CCC1C(NC)=O)=O Chemical compound CC(N(CC1)CCC1C(NC)=O)=O DFZQNOGIAYRJHX-UHFFFAOYSA-N 0.000 description 1
ZCZZRLOIAIYSOR-UHFFFAOYSA-N CC(N(CC1)CCC1c1c[nH]cn1)=O Chemical compound CC(N(CC1)CCC1c1c[nH]cn1)=O ZCZZRLOIAIYSOR-UHFFFAOYSA-N 0.000 description 1
OZUNEUWWLWXNFV-UHFFFAOYSA-N CC(N(CC1)CCC1c1nnn[nH]1)=O Chemical compound CC(N(CC1)CCC1c1nnn[nH]1)=O OZUNEUWWLWXNFV-UHFFFAOYSA-N 0.000 description 1
RTDVGURMKIOHHE-MRVPVSSYSA-N CC(N(CC1)[C@@H](CO)CN1C=O)=O Chemical compound CC(N(CC1)[C@@H](CO)CN1C=O)=O RTDVGURMKIOHHE-MRVPVSSYSA-N 0.000 description 1
ODPIDTOGVIDBLN-UHFFFAOYSA-N CC(N(CCC1)CC1C(O)=O)=O Chemical compound CC(N(CCC1)CC1C(O)=O)=O ODPIDTOGVIDBLN-UHFFFAOYSA-N 0.000 description 1
OPNUSWOVLSLCEQ-UHFFFAOYSA-N CC(N(CCC1O)CC1O)=O Chemical compound CC(N(CCC1O)CC1O)=O OPNUSWOVLSLCEQ-UHFFFAOYSA-N 0.000 description 1
VBPJTSXLCAQVRV-UHFFFAOYSA-N CC(N1CC(CC(O)=O)CC1)=O Chemical compound CC(N1CC(CC(O)=O)CC1)=O VBPJTSXLCAQVRV-UHFFFAOYSA-N 0.000 description 1
NOKVBXLRXBZIEU-UHFFFAOYSA-N CC(N1CC(CN(C)C2)C2C1)=O Chemical compound CC(N1CC(CN(C)C2)C2C1)=O NOKVBXLRXBZIEU-UHFFFAOYSA-N 0.000 description 1
SPVDEFLVIBQUIQ-UHFFFAOYSA-N CC(N1CC(CO)CCC1)=O Chemical compound CC(N1CC(CO)CCC1)=O SPVDEFLVIBQUIQ-UHFFFAOYSA-N 0.000 description 1
SPNAWRHVQZEFHH-UHFFFAOYSA-N CC(N1CCC(CC(O)=O)CC1)=O Chemical compound CC(N1CCC(CC(O)=O)CC1)=O SPNAWRHVQZEFHH-UHFFFAOYSA-N 0.000 description 1
WRAGCBBWIYQMRF-UHFFFAOYSA-N CC(NC1CCCCC1)=O Chemical compound CC(NC1CCCCC1)=O WRAGCBBWIYQMRF-UHFFFAOYSA-N 0.000 description 1
YMLMNCAFOVWVSV-UHFFFAOYSA-N CC(NCCNC)=O Chemical compound CC(NCCNC)=O YMLMNCAFOVWVSV-UHFFFAOYSA-N 0.000 description 1
BIJAWQUBRNHZGE-UHFFFAOYSA-N CC(Nc1ccncc1)=O Chemical compound CC(Nc1ccncc1)=O BIJAWQUBRNHZGE-UHFFFAOYSA-N 0.000 description 1
PVDYNYCZGYOXAF-UHFFFAOYSA-N CC(OCCF)=O Chemical compound CC(OCCF)=O PVDYNYCZGYOXAF-UHFFFAOYSA-N 0.000 description 1
UTCHFKZCDUFRSE-LURJTMIESA-N CC([C@@H](CCN1)CC1=O)=O Chemical compound CC([C@@H](CCN1)CC1=O)=O UTCHFKZCDUFRSE-LURJTMIESA-N 0.000 description 1
FVKWOWXKTBIIJU-KYZUINATSA-N CC([C@H](CC1)CC[C@@H]1C(OC)=O)=O Chemical compound CC([C@H](CC1)CC[C@@H]1C(OC)=O)=O FVKWOWXKTBIIJU-KYZUINATSA-N 0.000 description 1
MERSCMBQVRTJPC-KYZUINATSA-N CC([C@H](CC1)CC[C@@H]1S(C)(=O)=O)=O Chemical compound CC([C@H](CC1)CC[C@@H]1S(C)(=O)=O)=O MERSCMBQVRTJPC-KYZUINATSA-N 0.000 description 1
VTODLKPQIHLMBW-ZKCHVHJHSA-N CC([C@H](CC1)CC[C@@H]1c1nnn[nH]1)=O Chemical compound CC([C@H](CC1)CC[C@@H]1c1nnn[nH]1)=O VTODLKPQIHLMBW-ZKCHVHJHSA-N 0.000 description 1
LDHQMPWYKOPGCI-OCAPTIKFSA-N CC([C@H](CC1)CC[C@H]1O)=O Chemical compound CC([C@H](CC1)CC[C@H]1O)=O LDHQMPWYKOPGCI-OCAPTIKFSA-N 0.000 description 1
RTNGNQPXORRHIO-ZCFIWIBFSA-N CC([C@H](CC1)CN1S=O)=O Chemical compound CC([C@H](CC1)CN1S=O)=O RTNGNQPXORRHIO-ZCFIWIBFSA-N 0.000 description 1
SOMDLFMGMLQPER-ZCFIWIBFSA-N CC([C@H](CC1)CS1(=O)=O)=O Chemical compound CC([C@H](CC1)CS1(=O)=O)=O SOMDLFMGMLQPER-ZCFIWIBFSA-N 0.000 description 1
UTCHFKZCDUFRSE-ZCFIWIBFSA-N CC([C@H](CCN1)CC1=O)=O Chemical compound CC([C@H](CCN1)CC1=O)=O UTCHFKZCDUFRSE-ZCFIWIBFSA-N 0.000 description 1
URIQDHYCWUWCNZ-WAAGHKOSSA-N CC([C@](CC1)(CC[C@@H]1C(O)=O)OC)=O Chemical compound CC([C@](CC1)(CC[C@@H]1C(O)=O)OC)=O URIQDHYCWUWCNZ-WAAGHKOSSA-N 0.000 description 1
URIQDHYCWUWCNZ-CZMCAQCFSA-N CC([C@](CC1)(CC[C@H]1C(O)=O)OC)=O Chemical compound CC([C@](CC1)(CC[C@H]1C(O)=O)OC)=O URIQDHYCWUWCNZ-CZMCAQCFSA-N 0.000 description 1
UPOBVCUHXIUBQA-WAAGHKOSSA-N CC([C@](CF)(CC1)CC[C@H]1C(O)=O)=O Chemical compound CC([C@](CF)(CC1)CC[C@H]1C(O)=O)=O UPOBVCUHXIUBQA-WAAGHKOSSA-N 0.000 description 1
DMTBADYHWWNCFP-MGCOHNPYSA-N CC([C@]1(CC[C@@H](CO)CC1)OC)=O Chemical compound CC([C@]1(CC[C@@H](CO)CC1)OC)=O DMTBADYHWWNCFP-MGCOHNPYSA-N 0.000 description 1
DMTBADYHWWNCFP-AOOOYVTPSA-N CC([C@]1(CC[C@H](CO)CC1)OC)=O Chemical compound CC([C@]1(CC[C@H](CO)CC1)OC)=O DMTBADYHWWNCFP-AOOOYVTPSA-N 0.000 description 1
FRWKMOUDSUIDQA-HOMQSWHASA-N CC([C@]1(CF)CC[C@@H](CC(O)=O)CC1)=O Chemical compound CC([C@]1(CF)CC[C@@H](CC(O)=O)CC1)=O FRWKMOUDSUIDQA-HOMQSWHASA-N 0.000 description 1
IPFQIEUHWLHESS-UHFFFAOYSA-N CC(c(cc1)cc(S(N2)(=O)=O)c1C2=O)=O Chemical compound CC(c(cc1)cc(S(N2)(=O)=O)c1C2=O)=O IPFQIEUHWLHESS-UHFFFAOYSA-N 0.000 description 1
QBHDSQZASIBAAI-UHFFFAOYSA-N CC(c(cc1)ccc1C(O)=O)=O Chemical compound CC(c(cc1)ccc1C(O)=O)=O QBHDSQZASIBAAI-UHFFFAOYSA-N 0.000 description 1
QNTSFZXGLAHYLC-UHFFFAOYSA-N CC(c(cc1)ccc1C(OC)=O)=O Chemical compound CC(c(cc1)ccc1C(OC)=O)=O QNTSFZXGLAHYLC-UHFFFAOYSA-N 0.000 description 1
KYEMJVGXLJXCSM-UHFFFAOYSA-N CC(c1cc(N(C)C)ccc1)=O Chemical compound CC(c1cc(N(C)C)ccc1)=O KYEMJVGXLJXCSM-UHFFFAOYSA-N 0.000 description 1
JLNBERXWTAILLL-UHFFFAOYSA-N CCC(CC1)(CCS1(=O)=[O]C)C(C)=O Chemical compound CCC(CC1)(CCS1(=O)=[O]C)C(C)=O JLNBERXWTAILLL-UHFFFAOYSA-N 0.000 description 1
YEJJUJNTWYKFLS-UHFFFAOYSA-N CCC(N1CCCC1)=O Chemical compound CCC(N1CCCC1)=O YEJJUJNTWYKFLS-UHFFFAOYSA-N 0.000 description 1
ABMDIECEEGFXNC-UHFFFAOYSA-N CCC(NCC)=O Chemical compound CCC(NCC)=O ABMDIECEEGFXNC-UHFFFAOYSA-N 0.000 description 1
DVRZMWOQUDCAGI-UHFFFAOYSA-N CCCNCC(CC1)(CCS1(=O)=[O]C)C(I)=O Chemical compound CCCNCC(CC1)(CCS1(=O)=[O]C)C(I)=O DVRZMWOQUDCAGI-UHFFFAOYSA-N 0.000 description 1
WZIRJERBOVMNOV-UHFFFAOYSA-N CCNC(C(CC1)(CCS1(=O)=[O]C)C(I)=O)O Chemical compound CCNC(C(CC1)(CCS1(=O)=[O]C)C(I)=O)O WZIRJERBOVMNOV-UHFFFAOYSA-N 0.000 description 1
AMBDTBHJFINMSE-UHFFFAOYSA-N CCOC(CNC(C)=O)=O Chemical compound CCOC(CNC(C)=O)=O AMBDTBHJFINMSE-UHFFFAOYSA-N 0.000 description 1
UATPMCXWXNZKMH-HOMQSWHASA-N CC[C@](CC1)(CC[C@H]1C(O)=O)C(C)=O Chemical compound CC[C@](CC1)(CC[C@H]1C(O)=O)C(C)=O UATPMCXWXNZKMH-HOMQSWHASA-N 0.000 description 1
XELKLBIILGRXKI-UHFFFAOYSA-N CN(C)C(CC1)CCN1C(I)=O Chemical compound CN(C)C(CC1)CCN1C(I)=O XELKLBIILGRXKI-UHFFFAOYSA-N 0.000 description 1
WUJPDWAWKVDDTK-UHFFFAOYSA-N CN(C)CC(CC1)(CCS1(=O)=[O]C)C(I)=O Chemical compound CN(C)CC(CC1)(CCS1(=O)=[O]C)C(I)=O WUJPDWAWKVDDTK-UHFFFAOYSA-N 0.000 description 1
BTJNPGZRJJXIIA-UHFFFAOYSA-N CNC(C(CC1)(CCS1(=O)=[O]C)C(I)=O)=O Chemical compound CNC(C(CC1)(CCS1(=O)=[O]C)C(I)=O)=O BTJNPGZRJJXIIA-UHFFFAOYSA-N 0.000 description 1
PMJLPHNCFUZGGW-UHFFFAOYSA-N CS(c(cc1)ccc1C(I)=O)(=O)=O Chemical compound CS(c(cc1)ccc1C(I)=O)(=O)=O PMJLPHNCFUZGGW-UHFFFAOYSA-N 0.000 description 1
DPJHZJGAGIWXTD-UHFFFAOYSA-N CS(c(cc1)ccc1F)(=O)=O Chemical compound CS(c(cc1)ccc1F)(=O)=O DPJHZJGAGIWXTD-UHFFFAOYSA-N 0.000 description 1
OSSSINRHVSBAFU-CZMCAQCFSA-N C[C@](CC1)(CC[C@H]1C(O)=O)C(C)=O Chemical compound C[C@](CC1)(CC[C@H]1C(O)=O)C(C)=O OSSSINRHVSBAFU-CZMCAQCFSA-N 0.000 description 1
DHPDYFQBXCSPAZ-UHFFFAOYSA-N C[IH]C(N(CC1)CC1C#N)=O Chemical compound C[IH]C(N(CC1)CC1C#N)=O DHPDYFQBXCSPAZ-UHFFFAOYSA-N 0.000 description 1
SINLYCIEVFOGFW-UHFFFAOYSA-N O=C(c1cccnc1)I Chemical compound O=C(c1cccnc1)I SINLYCIEVFOGFW-UHFFFAOYSA-N 0.000 description 1
JXOMISUNXUNMGN-UHFFFAOYSA-N OC(c1cccc(F)c1CO[I](C(F)(F)F)C(F)(F)F)=O Chemical compound OC(c1cccc(F)c1CO[I](C(F)(F)F)C(F)(F)F)=O JXOMISUNXUNMGN-UHFFFAOYSA-N 0.000 description 1
ZCDZYJYLGSORIU-UHFFFAOYSA-N OCC(C1)NCCN1C=O Chemical compound OCC(C1)NCCN1C=O ZCDZYJYLGSORIU-UHFFFAOYSA-N 0.000 description 1
YPWSASPSYAWQRK-UHFFFAOYSA-N OCCc1cccnc1 Chemical compound OCCc1cccnc1 YPWSASPSYAWQRK-UHFFFAOYSA-N 0.000 description 1

JP2016562465A 2014-01-06 2015-01-05 ＲＯＲγ調節因子としてのピロリジニルスルホン誘導体およびその使用 Expired - Fee Related JP6530764B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201461923896P	2014-01-06	2014-01-06
US61/923,896		2014-01-06
PCT/US2015/010089 WO2015103509A1 (fr)	2014-01-06	2015-01-05	Dérivés de pyrrolidinyle sulfone et leur utilisation en tant que modulateurs de ror gamma

Publications (3)

Publication Number	Publication Date
JP2017501236A JP2017501236A (ja)	2017-01-12
JP2017501236A5 true JP2017501236A5 (fr)	2018-02-15
JP6530764B2 JP6530764B2 (ja)	2019-06-12

Family

ID=52359012

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2016562465A Expired - Fee Related JP6530764B2 (ja)	2014-01-06	2015-01-05	ＲＯＲγ調節因子としてのピロリジニルスルホン誘導体およびその使用

Country Status (11)

Country	Link
US (2)	US20160326108A1 (fr)
EP (1)	EP3092229B1 (fr)
JP (1)	JP6530764B2 (fr)
CN (1)	CN106061971B (fr)
AR (1)	AR099029A1 (fr)
CA (1)	CA2936116A1 (fr)
EA (1)	EA030849B1 (fr)
ES (1)	ES2669208T3 (fr)
MX (1)	MX369347B (fr)
TW (1)	TW201609634A (fr)
WO (1)	WO2015103509A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6407285B2 (ja)	2013-09-09	2018-10-17	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	ＲＯＲγ調節因子
JP6397488B2 (ja)	2013-09-20	2018-09-26	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	ＲＯＲγ調節因子
WO2015103508A1 (fr)	2014-01-06	2015-07-09	Bristol-Myers Squibb Company	Composés sulfone carbocyclique servant de modulateurs de rorγ
WO2015103510A1 (fr)	2014-01-06	2015-07-09	Bristol-Myers Squibb Company	Sulfone hétérocyclique utilisé en tant que modulateurs de ror gamma
CN106061947B (zh)	2014-01-06	2019-12-03	百时美施贵宝公司	环己基砜RORγ调节剂
TWI667230B (zh)	2014-10-30	2019-08-01	比利時商健生藥品公司	用作ＲＯＲγｔ調節劑之三氟甲基醇
EP3212641B1 (fr)	2014-10-30	2018-12-05	Janssen Pharmaceutica NV	Thiazoles en tant que modulateurs de roryt
WO2016069978A1 (fr)	2014-10-30	2016-05-06	Janssen Pharmaceutica Nv	Thiazoles à substitution amide utilisés comme modulateurs de rorγt
KR102114536B1 (ko)	2015-05-07	2020-05-22	브리스톨-마이어스 스큅 컴퍼니	RORγ 조정제로서의 트리시클릭 술폰
WO2017170830A1 (fr) *	2016-03-31	2017-10-05	武田薬品工業株式会社	Composé hétérocyclique
TW201803869A (zh)	2016-04-27	2018-02-01	健生藥品公司	作為ＲＯＲγＴ調節劑之６－胺基吡啶－３－基噻唑
EP3523279A1 (fr)	2016-10-10	2019-08-14	Bristol-Myers Squibb Company	Sulfones tricycliques en tant que modulateurs de ror gamma
ES2872005T3 (es) *	2016-10-13	2021-11-02	Bristol Myers Squibb Co	Sulfonas heterocíclicas como moduladores de ROR gamma
US10435369B2 (en)	2016-11-09	2019-10-08	Bristol-Myers Squibb Company	Tricyclic sulfones as ROR gamma modulators
EP3538522A1 (fr) *	2016-11-10	2019-09-18	Bristol-Myers Squibb Company	Modulateurs de ror gamma
CA3103770A1 (fr)	2018-06-18	2019-12-26	Janssen Pharmaceutica Nv	Imidazoles substitues par phenyle et pyridinyle utilises en tant que modulateurs de roryt
JP2021528405A (ja)	2018-06-18	2021-10-21	ヤンセンファーマシューティカエヌ．ベー．	ＲＯＲγｔのモジュレータとしてのアミド置換チアゾール
EP3806958B1 (fr)	2018-06-18	2022-09-07	Janssen Pharmaceutica NV	6-aminopyridin-3-yl pyrazoles en tant que modulateurs de roryt
ES2925473T3 (es)	2018-06-18	2022-10-18	Janssen Pharmaceutica Nv	Pirazoles de piridinilo como moduladores de RORyt
WO2020113094A1 (fr)	2018-11-30	2020-06-04	Nuvation Bio Inc.	Composés pyrrole et pyrazole et leurs procédés d'utilisation
WO2020231713A1 (fr) *	2019-05-13	2020-11-19	Bristol-Myers Squibb Company	Agonists de ror-gammat

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0108591D0 (en) *	2001-04-05	2001-05-23	Merck Sharp & Dohme	Therapeutic agents
US20140243302A1 (en)	2011-06-27	2014-08-28	Merck Sharp & Dohme Corporation	Bridged bicyclic compounds for the treatment of bacterial infections
US20130190356A1 (en) *	2011-12-22	2013-07-25	Genentech, Inc.	Benzyl sulfonamide derivatives as rorc modulators
MX363350B (es) *	2012-05-08	2019-03-20	Merck Sharp & Dohme	COMPUESTOS DE SULFONA BICÍCLICA PARA LA INHIBICIÓN DE LA ACTIVIDAD RORgamma Y EL TRATAMIENTO DE ENFERMEDADES.
AR091279A1 (es)	2012-06-08	2015-01-21	Gilead Sciences Inc	Inhibidores macrociclicos de virus flaviviridae
WO2014028669A1 (fr) *	2012-08-15	2014-02-20	Biogen Idec Ma Inc.	Nouveaux composés pour la modulation de l'activité ror-gamma
WO2015103508A1 (fr)	2014-01-06	2015-07-09	Bristol-Myers Squibb Company	Composés sulfone carbocyclique servant de modulateurs de rorγ
CN106061947B (zh)	2014-01-06	2019-12-03	百时美施贵宝公司	环己基砜RORγ调节剂
WO2015103510A1 (fr)	2014-01-06	2015-07-09	Bristol-Myers Squibb Company	Sulfone hétérocyclique utilisé en tant que modulateurs de ror gamma

2015
- 2015-01-05 WO PCT/US2015/010089 patent/WO2015103509A1/fr not_active Ceased
- 2015-01-05 JP JP2016562465A patent/JP6530764B2/ja not_active Expired - Fee Related
- 2015-01-05 US US15/109,719 patent/US20160326108A1/en not_active Abandoned
- 2015-01-05 CN CN201580011338.XA patent/CN106061971B/zh not_active Expired - Fee Related
- 2015-01-05 EA EA201691368A patent/EA030849B1/ru not_active IP Right Cessation
- 2015-01-05 ES ES15700613.1T patent/ES2669208T3/es active Active
- 2015-01-05 EP EP15700613.1A patent/EP3092229B1/fr not_active Not-in-force
- 2015-01-05 CA CA2936116A patent/CA2936116A1/fr not_active Abandoned
- 2015-01-05 MX MX2016008845A patent/MX369347B/es active IP Right Grant
- 2015-01-05 TW TW104100097A patent/TW201609634A/zh unknown
- 2015-01-06 AR ARP150100016A patent/AR099029A1/es unknown
- 2015-01-06 US US14/590,233 patent/US9458171B2/en active Active

Publication	Publication Date	Title
JP2017501236A5 (fr)	2018-02-15
JP2017509689A5 (fr)	2018-02-15
JP2016501185A5 (fr)	2016-11-24
JP2017508782A5 (fr)	2018-01-25
JP2019537570A5 (fr)	2020-04-30
JP2017501237A5 (fr)	2018-01-25
JP2016506368A5 (fr)	2016-11-17
JP2018510139A5 (fr)	2019-03-14
JP2016506369A5 (fr)	2017-11-30
JP2016506935A5 (fr)	2017-11-30
JP2015143283A5 (fr)	2015-09-17
JP2017537080A5 (fr)	2018-11-22
JP2015537020A5 (fr)	2018-02-01
JP2014508811A5 (fr)	2015-05-07
JP2016518437A5 (fr)	2017-10-12
JP2013537203A5 (fr)	2014-05-22
JP2016500661A5 (fr)	2016-11-10
JP2015520140A5 (fr)	2016-06-16
JP2016503797A5 (fr)	2016-12-28
JP2017514910A5 (fr)	2018-06-14
JP2013543842A5 (fr)	2014-11-06
JP2018537535A5 (fr)	2020-01-23
JP2016531126A5 (fr)	2017-09-28
JP2017517538A5 (fr)	2018-07-12
JP2017506666A5 (fr)	2018-02-22